AMP-activated Protein Kinase α2 Subunit Is Required for the Preservation of Hepatic Insulin Sensitivity by n-3 Polyunsaturated Fatty Acids
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The induction of obesity, dyslipidemia, and insulin resistance by high-fat diet in rodents can be prevented by n-3 long-chain polyunsaturated fatty acids (LC-PUFAs). We tested a hypothesis whether AMP-activated protein kinase (AMPK) has a role in the beneficial effects of n-3 LC-PUFAs. RESEARCH DESIGN AND METHODS: Mice with a whole-body deletion of the α2 catalytic subunit of AMPK (AMPKα2(-/-)) and their wild-type littermates were fed on either a low-fat chow, or a corn oil-based high-fat diet (cHF), or a cHF diet with 15% lipids replaced by n-3 LC-PUFA concentrate (cHF+F). RESULTS: Feeding a cHF diet induced obesity, dyslipidemia, hepatic steatosis, and whole-body insulin resistance in mice of both genotypes. Although cHF+F feeding increased hepatic AMPKα2 activity, the body weight gain, dyslipidemia, and the accumulation of hepatic triglycerides were prevented by the cHF+F diet to a similar degree in both AMPKα2(-/-) and wild-type mice in ad libitum-fed state. However, preservation of hepatic insulin sensitivity by n-3 LC-PUFAs required functional AMPKα2 and correlated with the induction of adiponectin and reduction in liver diacylglycerol content. Under hyperinsulinemic-euglycemic conditions, AMPKα2 was essential for preserving low levels of both hepatic and plasma triglycerides, as well as plasma free fatty acids, in response to the n-3 LC-PUFA treatment. CONCLUSIONS: Our results show that n-3 LC-PUFAs prevent hepatic insulin resistance in an AMPKα2-dependent manner and support the role of adiponectin and hepatic diacylglycerols in the regulation of insulin sensitivity. AMPKα2 is also essential for hypolipidemic and antisteatotic effects of n-3 LC-PUFA under insulin-stimulated conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, knockout of AMPK subunit alpha 2 abrogates the improvement in hepatic insulin sensitivity by omega-3 PUFAs during a high fat diet despite studies observing little interaction between omega-3 PUFAs and AMPK [142].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 15×
“When insulin and glucose levels are high, such as during hyperinsulinemic-euglycemic clamp, wild-type mice fed n-3 LC-PUFAs exhibit improved hepatic insulin sensitivity and decreased plasma levels of NEFAs as compared with high-fat diet-fed controls.”
BackgroundInfluentialKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“energy levels, namely, the partitioning between lipid oxidation and lipogenesis (29,30).”
BackgroundLKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
The AMP-activated protein kinase cascade – a unifying system for energy control
Carling, D. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.11.005 · Cited by 1,112 · cited 1×
“AMPK is a heterotrimeric protein consisting of a catalytic -subunit and regulatory - and -subunits, with multiple isoforms identified for each subunit [ 1, 2, 1, 2, 1, 2, and 3; reviewed in ref (25)].”
BackgroundAMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,026 · cited 2×
“Four-month-old whole-body AMPK 2 / mice (29) backcrossed to C57BL/6J mice for nine generations, and wild-type littermate controls were fed on either Chow, cHF, or cHF F diet for nine weeks.”
BackgroundMethodForetz, M., Guichard, C., Ferré, P., & Foufelle, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12737 · Cited by 747 · cited 1×
“Hepatocytes were isolated from livers of fed mice by a modification of the collagenase method (34) and seeded at a density of 0.”
MethodFish Oil Prevents Insulin Resistance Induced by High-Fat Feeding in Rats
Storlien, L. H., Kraegen, E. W., Chisholm, D. J., Ford, G. L., Bruce, D. G., & Pascoe, W. S. (1987) · Science · doi:10.1126/science.3303333 · Cited by 650 · cited 2×
“Previous animal studies demonstrated that n-3 LC-PUFAs could counteract the development of both hepatic steatosis (8,18,36,37) and hepatic insulin resistance (8,9,16), while suppressing lipogenesis and augmenting lipid catabolism in the liver (8,13,19,21).”
BackgroundNawrocki, A. R., Rajala, M. W., Tomas, E., Pajvani, U. B., Saha, A. K., Trumbauer, M. E., Pang, Z., Chen, A. S., Ruderman, N. B., Chen, H., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505311200 · Cited by 639 · cited 1×
“nes, whereas mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to these compounds (48).”
BackgroundCharacterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding
CHEUNG, P. C. F., SALT, I. P., DAVIES, S. P., HARDIE, D. G., & CARLING, D. (2000) · Biochemical Journal · doi:10.1042/bj3460659 · Cited by 637 · cited 1×
“AMPK 1 and AMPK 2 contribute equally to total AMPK activity in the liver (50).”
Background
Cited by
AMPK, insulin resistance, and the metabolic syndrome
Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67227 · Cited by 873
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
Rossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038834 · Cited by 230
Self-citationLipid signaling in adipose tissue: Connecting inflammation & metabolism
Masoodi, M., Kuda, O., Rossmeisl, M., Flachs, P., & Kopecky, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.023 · Cited by 221
Self-citationOmega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome
Martínez-Fernández, L., Laiglesia, L. M., Huerta, A. E., Martínez, J. A., & Moreno-Aliaga, M. J. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.07.003 · Cited by 212
Omega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
“It may be of interest to assess the importance of AMPK on insulin sensitizing effects of omega-3 PUFAs in skeletal muscle.”
BackgroundThe Effect of n-3 Fatty Acids on Glucose Homeostasis and Insulin Sensitivity
FLACHS, P., ROSSMEISL, M., & KOPECKY, J. (2014) · Physiological Research · doi:10.33549/physiolres.932715 · Cited by 183
“…with omega-3 treatment primarily involves improved hepatic insulin sensitivity (Storlien et al. 1987, Neschen et al. 2007, Kuda et al. 2009, Jelenik et al. 2010) associated with reduced hepatic diacylglycerol accumulation (Neschen et al. 2007, Jelenik et al. 2010), reduced TAG deposition…”
BackgroundInfluentialSelf-citationNegative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53
Jiang, P., Ren, L., Zhi, L., Yu, Z., Lv, F., Xu, F., Peng, W., Bai, X., Cheng, K., Quan, L., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.008 · Cited by 168
Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice
Laiglesia, L. M., Lorente-Cebrián, S., Martínez-Fernández, L., Sáinz, N., Prieto-Hontoria, P. L., Burrell, M. A., Rodríguez-Ortigosa, C. M., Martínez, J. A., & Moreno-Aliaga, M. J. (2018) · International Journal of Obesity · doi:10.1038/ijo.2017.226 · Cited by 167
Rohm, M., Schäfer, M., Laurent, V., Üstünel, B. E., Niopek, K., Algire, C., Hautzinger, O., Sijmonsma, T., Zota, A., Medříková, D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4171 · Cited by 160
Flachs, P., Rossmeisl, M., Kuda, O., & Kopecky, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.003 · Cited by 149
“imal studies showed anti-obesity effects of omega 3 [27,66,207, 208,214], while human studies documenting lower accumulation of”
BackgroundSelf-citationWang, Q., Zhang, M., Liang, B., Shirwany, N., Zhu, Y., & Zou, M.-H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025436 · Cited by 143
Sun, Y., Zhou, S., Guo, H., Zhang, J., Ma, T., Zheng, Y., Zhang, Z., & Cai, L. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154002 · Cited by 148
Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?
Lalia, A., & Lanza, I. (2016) · Nutrients · doi:10.3390/nu8060329 · Cited by 141
Lanza, I. R., Blachnio-Zabielska, A., Johnson, M. L., Schimke, J. M., Jakaitis, D. R., Lebrasseur, N. K., Jensen, M. D., Sreekumaran Nair, K., & Zabielski, P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2012 · Cited by 135
Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
Horakova, O., Kroupova, P., Bardová, K., Buresova, J., Janovská, P., Kopecký, J., & Rossmeisl, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-42531-0 · Cited by 145
Self-citationInflammation and intracellular metabolism: new targets in OA
Liu‐Bryan, R. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.12.016 · Cited by 123
Flachs, P., Rühl, R., Hensler, M., Janovská, P., Zouhar, P., Kůs, V., Jílková, Z. M., Papp, E., Kuda, O., Svobodová, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2233-2 · Cited by 118
“As already described [13, 30], food consumption was not affected by dietary LC n-3 PUFA (Table 1).”
BackgroundMethodSelf-citationOmega-3 fatty acids and adipose tissue biology
Kuda, O., Rossmeisl, M., & Kopecky, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.004 · Cited by 100
Self-citationTwo non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis
Silvestri, C., Paris, D., Martella, A., Melck, D. J., Guadagnino, I., Cawthorne, M., Motta, A., & Marzo, V. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.001 · Cited by 115
Kim, O. Y., & Song, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122356 · Cited by 102
Rossmeisl, M., Medříková, D., van Schothorst, E. M., Pavlišová, J., Kuda, O., Hensler, M., Bardová, K., Flachs, P., Staňková, B., Vecka, M., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.010 · Cited by 103
Self-citationCavaliere, G., Trinchese, G., Bergamo, P., De Filippo, C., Mattace Raso, G., Gifuni, G., Putti, R., Moni, B. H., Canani, R. B., Meli, R., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149033 · Cited by 87
Martins, A. R., Crisma, A. R., Masi, L. N., do Amaral, C. L., Marzuca-Nassr, G. N., Bomfim, L. H. M., Teodoro, B. G., Queiroz, A. L., Serdan, T. D. A., Torres, R. P., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.012 · Cited by 95
Mitochondrial Plasticity in Obesity and Diabetes Mellitus
Jelenik, T., & Roden, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4910 · Cited by 73
Horakova, O., Medrikova, D., van Schothorst, E. M., Bunschoten, A., Flachs, P., Kus, V., Kuda, O., Bardova, K., Janovska, P., Hensler, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043764 · Cited by 70
Self-citationRho-Kinase Inhibition Ameliorates Metabolic Disorders through Activation of AMPK Pathway in Mice
Noda, K., Nakajima, S., Godo, S., Saito, H., Ikeda, S., Shimizu, T., Enkhjargal, B., Fukumoto, Y., Tsukita, S., Yamada, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110446 · Cited by 67
AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1
Yin, Y., Li, Z., Gao, L., Li, Y., Zhao, J., & Zhang, W. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.006 · Cited by 62
JANOVSKÁ, P., FLACHS, P., KAZDOVÁ, L., & KOPECKÝ, J. (2013) · Physiological Research · doi:10.33549/physiolres.932464 · Cited by 61
“…syndrome in dietary obese https://doi.org/10.33549/physiolres.932464 154 Janovská et al. Vol. 62 mice (Kuda et al. 2009, van Schothorst et al. 2009, Jelenik et al. 2010, Flachs et al. 2011, Hensler et al. 2011, Kus et al. 2011, Rossmeisl et al. 2012), which have also demonstrated that LC n-3 PUFA…”
BackgroundResultInfluentialSelf-citationJelenik, T., Séquaris, G., Kaul, K., Ouwens, D. M., Phielix, E., Kotzka, J., Knebel, B., Weiß, J., Reinbeck, A. L., Janke, L., et al. (2014) · Diabetes · doi:10.2337/db13-1794 · Cited by 56
Effect of intrauterine growth retardation on liver and long-term metabolic risk
Cianfarani, S., Agostoni, C. V., Bedogni, G., Canani, R. B., Brambilla, P., Nobili, V., & Pietrobelli, A. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.54 · Cited by 60
Fish oil supplementation for two generations increases insulin sensitivity in rats
Hirabara, S. M., Folador, A., Fiamoncini, J., Lambertucci, R. H., Rodrigues, C., Rocha, M. S., Aikawa, J., Yamazaki, R. K., Martins, A. R., Rodrigues, A. C., et al. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.08.014 · Cited by 54
Guo, Y., Huang, D., Chen, F., Ma, S., Zhou, W., Zhang, W., & Mai, K. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.736040 · Cited by 57
n-3 fatty acids modulate adipose tissue inflammation and oxidative stress
Fan, C., Zirpoli, H., & Qi, K. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32835c02c8 · Cited by 50
Kůs, V., Flachs, P., Kuda, O., Bardová, K., Janovská, P., Svobodová, M., Jílková, Z. M., Rossmeisl, M., Wang‐Sattler, R., Yu, Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027126 · Cited by 56
Self-citationMatravadia, S., Herbst, E. A. F., Jain, S. S., Mutch, D. M., & Holloway, G. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2014 · Cited by 46
Augmenting energy expenditure by mitochondrial uncoupling: A role of AMP-activated protein kinase
Klaus, S., Keipert, S., Rossmeisl, M., & Kopecky, J. (2012) · Genes & Nutrition · doi:10.1007/s12263-011-0260-8 · Cited by 44
Self-citationThe inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice
Hensler, M., Bardova, K., Jilkova, Z. M., Wahli, W., Meztger, D., Chambon, P., Kopecky, J., & Flachs, P. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-128 · Cited by 44
“feeding cHF+F diet, see Methods) prevented dietary induced obesity and associated metabolic disorders [2-4].”
BackgroundResultSelf-citationLudwig, T., Worsch, S., Heikenwälder, M. F., Daniel, H., Hauner, H., & Bader, B. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00171.2012 · Cited by 51
“In the present study, the reduction of adipose tissue mass and the low levels of hepatic TAG and plasma NEFA and SAA in HF/n-3 compared with HF mice point to an amelioration of adipose tissue inflammation.”
BackgroundInfluentialA role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses
Qi, T., Chen, Y., Li, H., Pei, Y., Woo, S., Guo, X., Zhao, J., Qian, X., Awika, J. M., Huo, Y., et al. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0066 · Cited by 47
“In adipocytes, the α1 catalytic subunit is the predominant isoform and accounts for the major part of AMPK activity (Daval et al. 2005) whereas in hepatocytes α2-subunit is the main functional isoform of AMPK (Andreelli et al. 2006, Jelenik et al. 2010).”
BackgroundBellini, L., Campaña, M. B., Rouch, C., Chacińska, M., Bugliani, M., Meneyrol, K., Hainault, I., Lenoir, V., Denom, J., Véret, J., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4629-8 · Cited by 39
Sistilli, G., Kalendová, V., Čajka, T., Irodenko, I., Bardová, K., Oseeva, M., Žáček, P., Kroupova, P., Horakova, O., Lackner, K., et al. (2021) · Nutrients · doi:10.3390/nu13020437 · Cited by 45
Self-citationPavlišová, J., Bardová, K., Staňková, B., TVRZICKÁ, E., Kopecký, J., & Rossmeisl, M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.07.001 · Cited by 43
Self-citationAMP-Activated Protein Kinase α1 Protects Against Diet-Induced Insulin Resistance and Obesity
(2012) · Diabetes · doi:10.2337/db11-1373 · Cited by 38
Self-citationRetractedWang, Q., & Wang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512117 · Cited by 44
“In HepG2 hepatocyte assays, a decreased LA/ALA ratio led to increased phosphorylation of AMP-activated protein kinase (AMPK) and its downstream target, acetyl coenzyme A carboxylase (ACC) [40,41].”
BackgroundAMP-activated protein kinase is required for the anti-adipogenic effects of alpha-linolenic acid
Zhou, X., Wu, W.-C., Chen, J., Wang, X., & Wang, Y. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0006-5 · Cited by 37
Gao, L., Tang, H. Y., Zeng, Q., Tang, T. S., Chen, M., & Pu, P. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.06.005 · Cited by 33
Lin, D., He, H., Hua, J., Willis, J., Willard, L., Jiang, Y., Medeiros, D. M., Wark, L., Han, J., Liu, Y., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300186 · Cited by 32
Kroupova, P., van Schothorst, E. M., Keijer, J., Bunschoten, A., Vodička, M., Irodenko, I., Oseeva, M., Žáček, P., Kopecký, J., Rossmeisl, M., et al. (2020) · Nutrients · doi:10.3390/nu12072037 · Cited by 30
“While the molecular targets of Omega-3 in liver [8], WAT [5,6,9] or muscle [7,13] have been intensively studied, the contribution of other organs to the overall metabolic effect of Omega-3 is still little characterized.”
BackgroundSelf-citationRossmeisl, M., Pavlišová, J., Janovská, P., Kuda, O., Bardová, K., Hansíková, J., Svobodová, M., Oseeva, M., Veleba, J., Kopecký, J., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.03.011 · Cited by 32
Self-citationDietary fish oil regulates gene expression of cholesterol and bile acid transporters in mice
Kamisako, T., Tanaka, Y., Ikeda, T., Yamamoto, K., & Ogawa, H. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00924.x · Cited by 27
Fibroblast Growth Factor‐21 and the Beneficial Effects of Long‐Chain n‐3 Polyunsaturated Fatty Acids
Villarroya, J., Flachs, P., Redondo‐Angulo, I., Giralt, M., Medříková, D., Villarroya, F., Kopecký, J., & Planavila, A. (2014) · Lipids · doi:10.1007/s11745-014-3948-x · Cited by 30
Self-citationMitrovic, M., Sistilli, G., Horakova, O., & Rossmeisl, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13650 · Cited by 29
Self-citationRossmeisl, M., Pavlišová, J., Bardová, K., Kalendová, V., Buresova, J., Kuda, O., Kroupova, P., Staňková, B., TVRZICKÁ, E., Fišerová, E., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158732 · Cited by 27
Self-citationSharma, P., & Agnihotri, N. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108458 · Cited by 27
Animal Models of Nutritional Induction of Type 2 Diabetes Mellitus
Barbosa‐da‐Silva, S., Sarmento, I. B., Bargut, T. C. L., Souza‐Mello, V., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2014) · International Journal of Morphology · doi:10.4067/s0717-95022014000100046 · Cited by 27
“In the liver, n-3 PUFAs appear to improve and/or prevent hepatic IR via suppressing lipogenesis and stimulating lipid catabolism, decreasing fat accumulation (Jelenik et al., 2010).”
BackgroundLiu, M., Montgomery, M. K., Fiveash, C. E., Osborne, B., Cooney, G. J., Bell-Anderson, K. S., & Turner, N. A. (2014) · Scientific Reports · doi:10.1038/srep05538 · Cited by 26
Monaco, C. M. F., Proudfoot, R., Miotto, P. M., Herbst, E. A. F., MacPherson, R. E. K., & Holloway, G. P. (2017) · Diabetologia · doi:10.1007/s00125-017-4456-3 · Cited by 22
Sjövall, P., Rossmeisl, M., Hanrieder, J., Kuda, O., Kopecký, J., & Bryhn, M. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8515-7 · Cited by 23
Self-citationPinolenic Acid Downregulates Lipid Anabolic Pathway in HepG2 Cells
Lee, A. R., & Han, S. N. (2016) · Lipids · doi:10.1007/s11745-016-4149-6 · Cited by 19
Katsnelson, G., & Ceddia, R. B. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00304.2020 · Cited by 20
Pavlišová, J., Horakova, O., Kalendová, V., Buresova, J., Bardová, K., Holendová, B., Plecitá‐Hlavatá, L., Vacková, Š., Windrichová, J., Topolčan, O., et al. (2020) · Food & Function · doi:10.1039/d0fo01942a · Cited by 21
Self-citationHorakova, O., Hansíková, J., Bardová, K., Gardlo, A., Rombaldová, M., Kuda, O., Rossmeisl, M., & Kopecký, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155776 · Cited by 16
Self-citationAlgamas‐Dimantov, A., Yehuda‐Shnaidman, E., Hertz, R., Peri, I., Bar‐Tana, J., & Schwartz, B. (2014) · Oncotarget · doi:10.18632/oncotarget.2453 · Cited by 16
Slámová, K., Papoušek, F., Janovská, P., Kopecký, J., & Kolář, F. (2016) · Physiological Research · doi:10.33549/physiolres.932979 · Cited by 15
“Our previous results on the functional significance of AMPK in the liver support the later possibility (Jeleník et al. 2010).”
MethodResultNasri, A., Kowaluk, M., Widenmaier, S. B., & Unniappan, S. (2024) · Communications Biology · doi:10.1038/s42003-024-06314-2 · Cited by 13
Dai, Y., Yang, F., Zhou, N., Sha, L., Zhou, S., Wang, J., & Li, X. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516003718 · Cited by 11
Xue, B., Hong, Q., Li, X., Lu, M., Zhou, J., Yue, S., Wang, Z., Wang, L., Peng, Q., & Xue, B. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.745078 · Cited by 9
Buresova, J., Janovská, P., Kuda, O., Křížová, J., van der Stelt, I., Keijer, J., Hansíková, H., Rossmeisl, M., & Kopecký, J. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0281-0 · Cited by 9
Self-citationAlzoubi, M. R., & Al-Domi, H. A. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.024 · Cited by 11
“…inhibition of lipogenic transcription factors such as sterol regulatory element-binding protein-1c, nuclear factor-Y (Teran-Garcia et al., 2007) Moreover, EPA stimulate fatty acid oxidation via activation of PPARα and AMPK lead to improvements in hepatic insulin sensitivity (Jelenik et al., 2010).”
BackgroundSabinari, I. W., Horakova, O., Čajka, T., Kleinova, V., Wieckowski, M. R., & Rossmeisl, M. (2024) · Physiological Research · doi:10.33549/physiolres.935396 · Cited by 7
Self-citationNonalcoholic Fatty Liver Disease
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_9 · Cited by 6
Tung, Y., Chen, Y., Fan, T.-Y., Fong, T.-H., & Chiu, W. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20451 · Cited by 5
Zhou, X., Chen, J., Wu, W.-C., Wang, X., & Wang, Y. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002391 · Cited by 4
Medak, K. D., McKie, G. L., Peppler, W. T., Shamshoum, H., Dibe, H. A., Mutch, D. M., Josse, A. R., & Wright, D. C. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.09.003 · Cited by 2
Kopecký, J., & Zicha, J. (2015) · PubMed
Matravadia, S. (2016) · The Atrium (University of Guelph)
Barbosa‐da‐Silva, S., Sarmento, I. B., Bargut, T. C. L., Souza‐Mello, V., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2014)
Jeromson, S. (2017) · Stirling Online Research Repository (University of Stirling)
Fatty acid composition in four serum lipid fractions and the pathogenesis of diabetes
Johnston, L. (2017) · TSpace (University of Toronto)
Masi, L. N. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-19112014-094237 · Cited by 1
Rôle et régulation de la protéine kinase AMPK au niveau intestinal
Harmel, É. (2012) · theses.fr (ABES) · doi:10.70675/0223f181zd1b3z4a87zadd0zd62495c76b6c
Wang, S., Li, J., Song, C., Li, Q., Yang, H., & Chen, M. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178863
Durval, M. C., Brito, L. F., Fanalli, S. L., Ciconello, F. N., de Oliveira, C. S., Nascimento, L. E., da Silva, B. P. M., & César, A. S. M. (2026) · BMC Genomics · doi:10.1186/s12864-026-13086-y
“…and DHA can improve insulin sensitivity by remodeling the phospholipid composition of mitochondrial membranes [113], reducing the accumulation of reactive lipid intermediates in muscles [114], and enhancing the transcription of genes related to mitochondrial biogenesis and FA oxidation [115, 116].”
Qiao, H., Tang, C., Yu, W., He, J., Feng, Y., Zhang, C., Tao, J., Jia, X., Ma, T. M., Qie, L., et al. (2026) · PROTEOMICS · doi:10.1002/pmic.70162
Metadata
- Authors
- Jelenik, T., Rossmeisl, M., Kuda, O., Jilkova, Z. M., Medrikova, D., Kus, V., Hensler, M., Janovska, P., Miksik, I., Baranowski, M., Gorski, J., Hébrard, S., Jensen, T. E., Flachs, P., Hawley, S., Viollet, B., & Kopecky, J.
- Affiliations
- Department of Adipose Tissue Biology and the
- Department of Analysis of Biologically Important Compounds, Institute of Physiology of the Academy of Sciences of the Czech Republic, v.v.i., Prague, Czech Republic;
- Medical University of Białystok (PL)
- Department of Physiology, Medical University of Bialystok, Poland;
- Centre National de la Recherche Scientifique (FR)
- University of Copenhagen (DK)
- University of Dundee (GB)
- Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France;
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-06
- Volume
- 59
- Issue
- 11
- Pages
- 2737-2746
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963531
- OpenAlex
- W2136917561
- Cited by
- 88
- References
- 55
- Citations by year
- 2026: 3 · 2024: 2 · 2023: 4 · 2021: 5 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 9 · 2015: 10 · 2014: 14 · 2013: 6 · 2012: 9
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ASEP (submittedVersion, public-domain)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- AMPK, AMPKα2, n-3 long-chain polyunsaturated fatty acids, hepatic insulin sensitivity, insulin resistance, hepatic steatosis, adiponectin, diacylglycerol, dyslipidemia, obesity, high-fat diet, triglycerides, free fatty acids, hepatic lipid metabolism
- MeSH terms
- Animals, Dietary Fats, Fatty Acids, Unsaturated, Hyperinsulinism, Insulin Resistance, Liver, Glucose Clamp Technique, Fatty Acids, Omega-3, Mice, Knockout, Diet, Fat-Restricted, Cell Culture Techniques, Protein Subunits, Hepatocytes, Metabolic Syndrome, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.